Search Results - Lisha Tang
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Comparative efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy in HR+/HR2- patients with advanced or metastatic breast cancer: a systematic review and network... by Yuan Liu, Tongtong Ren, Xu Chen, Qinglan He, Xinchun Wang, Lisha Tang
Published in BMC Cancer (2025-10-01)Get full text
Article -
8
-
9
NRF2 maintains redox balance via ME1 and NRF2 inhibitor synergizes with venetoclax in NPM1-mutated acute myeloid leukemia by Jiayuan Hu, Zihao Yuan, Yan Shu, Jun Ren, Jing Yang, Lisha Tang, Xingyu Wei, Yongcan Liu, Fangfang Jin, Qiaoling Xiao, Xinyi Chen, Nan Wu, Wen Zhao, Ziwei Li, Ling Zhang
Published in Cancer & Metabolism (2025-06-01)Get full text
Article -
10
Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia by Jun Ren, Junpeng Huang, Zailin Yang, Minghui Sun, Jing Yang, Can Lin, Fangfang Jin, Yongcan Liu, Lisha Tang, Jiayuan Hu, Xingyu Wei, Xinyi Chen, Zihao Yuan, Zesong Yang, Yanmeng Chen, Ling Zhang
Published in Journal of Experimental & Clinical Cancer Research (2024-06-01)Get full text
Article -
11
Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia by Jing Yang, Ling Zhang, Nan Wu, Jiayuan Hu, Jun Ren, Xinyi Chen, Xingyu Wei, Minghui Sun, Ziwei Li, Yongcan Liu, Yan Shu, Genyou Li, Fangfang Jin, Can Lin, Lisha Tang, Zesong Yang
Published in Journal for ImmunoTherapy of Cancer (2025-07-01)Get full text
Article
